促进数字和移动医疗的社会实施:监管对东亚用户和非用户行为的影响。

IF 6.5 2区 医学 Q1 PHARMACOLOGY & PHARMACY Drug Discovery Today Pub Date : 2024-08-06 DOI:10.1016/j.drudis.2024.104136
Hanlin Feng , Makoto Niwa , Jianfei Cao , Karin Kurata , Shuo Zhang , Yenogjoo Lim , Tack Joong Kim , Xitong Guo , Itsuki Kageyama , Kota Kodama
{"title":"促进数字和移动医疗的社会实施:监管对东亚用户和非用户行为的影响。","authors":"Hanlin Feng ,&nbsp;Makoto Niwa ,&nbsp;Jianfei Cao ,&nbsp;Karin Kurata ,&nbsp;Shuo Zhang ,&nbsp;Yenogjoo Lim ,&nbsp;Tack Joong Kim ,&nbsp;Xitong Guo ,&nbsp;Itsuki Kageyama ,&nbsp;Kota Kodama","doi":"10.1016/j.drudis.2024.104136","DOIUrl":null,"url":null,"abstract":"<div><p>This study conducted policy and regulation analyses and user acceptance surveys in three East Asian countries with developed telecommunication infrastructure (China, South Korea, and Japan) to determine the most effective way to implement mobile health (mHealth). Regional differences in users’ emphasis on the purpose of mHealth, including medical information referral or health management, appear to be influenced by regional regulation, thus making regulation analysis important when considering mHealth penetration strategies. Potential mHealth users have high expectations for medical information and correspondence, which is crucial for the pharmaceutical industry in terms of providing information and retaining patients. Furthermore, potential users are willing to use the system medically, which is beneficial to the pharmaceutical industry when introducing mHealth and prescriptions in combination.</p></div>","PeriodicalId":301,"journal":{"name":"Drug Discovery Today","volume":"29 10","pages":"Article 104136"},"PeriodicalIF":6.5000,"publicationDate":"2024-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1359644624002617/pdfft?md5=9f4bb18440e57af47ac64b4282921428&pid=1-s2.0-S1359644624002617-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Promoting the social implementation of digital and mobile health: effects of regulation on user and non-user behavior in East Asia\",\"authors\":\"Hanlin Feng ,&nbsp;Makoto Niwa ,&nbsp;Jianfei Cao ,&nbsp;Karin Kurata ,&nbsp;Shuo Zhang ,&nbsp;Yenogjoo Lim ,&nbsp;Tack Joong Kim ,&nbsp;Xitong Guo ,&nbsp;Itsuki Kageyama ,&nbsp;Kota Kodama\",\"doi\":\"10.1016/j.drudis.2024.104136\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>This study conducted policy and regulation analyses and user acceptance surveys in three East Asian countries with developed telecommunication infrastructure (China, South Korea, and Japan) to determine the most effective way to implement mobile health (mHealth). Regional differences in users’ emphasis on the purpose of mHealth, including medical information referral or health management, appear to be influenced by regional regulation, thus making regulation analysis important when considering mHealth penetration strategies. Potential mHealth users have high expectations for medical information and correspondence, which is crucial for the pharmaceutical industry in terms of providing information and retaining patients. Furthermore, potential users are willing to use the system medically, which is beneficial to the pharmaceutical industry when introducing mHealth and prescriptions in combination.</p></div>\",\"PeriodicalId\":301,\"journal\":{\"name\":\"Drug Discovery Today\",\"volume\":\"29 10\",\"pages\":\"Article 104136\"},\"PeriodicalIF\":6.5000,\"publicationDate\":\"2024-08-06\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S1359644624002617/pdfft?md5=9f4bb18440e57af47ac64b4282921428&pid=1-s2.0-S1359644624002617-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Drug Discovery Today\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1359644624002617\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug Discovery Today","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1359644624002617","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

摘要

本研究在三个电信基础设施发达的东亚国家(中国、韩国和日本)进行了政策法规分析和用户接受度调查,以确定实施移动医疗(mHealth)的最有效方法。用户对移动医疗目的(包括医疗信息转介或健康管理)的重视程度存在地区差异,这似乎受到地区法规的影响,因此在考虑移动医疗渗透策略时,法规分析非常重要。移动医疗的潜在用户对医疗信息和通信有很高的期望,这对医药行业提供信息和留住病人至关重要。此外,潜在用户愿意在医疗方面使用该系统,这有利于制药业将移动医疗和处方结合起来。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Promoting the social implementation of digital and mobile health: effects of regulation on user and non-user behavior in East Asia

This study conducted policy and regulation analyses and user acceptance surveys in three East Asian countries with developed telecommunication infrastructure (China, South Korea, and Japan) to determine the most effective way to implement mobile health (mHealth). Regional differences in users’ emphasis on the purpose of mHealth, including medical information referral or health management, appear to be influenced by regional regulation, thus making regulation analysis important when considering mHealth penetration strategies. Potential mHealth users have high expectations for medical information and correspondence, which is crucial for the pharmaceutical industry in terms of providing information and retaining patients. Furthermore, potential users are willing to use the system medically, which is beneficial to the pharmaceutical industry when introducing mHealth and prescriptions in combination.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Drug Discovery Today
Drug Discovery Today 医学-药学
CiteScore
14.80
自引率
2.70%
发文量
293
审稿时长
6 months
期刊介绍: Drug Discovery Today delivers informed and highly current reviews for the discovery community. The magazine addresses not only the rapid scientific developments in drug discovery associated technologies but also the management, commercial and regulatory issues that increasingly play a part in how R&D is planned, structured and executed. Features include comment by international experts, news and analysis of important developments, reviews of key scientific and strategic issues, overviews of recent progress in specific therapeutic areas and conference reports.
期刊最新文献
Efficacy and challenges involving combination therapies in CLL. Strategic partnerships for AI-driven drug discovery: The role of relational dynamics. Antibody-drug conjugates: prospects for the next generation. Improving access to domestic innovative medicines: characteristics and trends of approved drugs in China 2010-2024. Beyond CL and VSS: A comprehensive approach to human pharmacokinetic predictions.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1